Journal
BIOCHEMISTRY
Volume 40, Issue 26, Pages 7812-7819Publisher
AMER CHEMICAL SOC
DOI: 10.1021/bi0102398
Keywords
-
Categories
Funding
- NIA NIH HHS [AG08470, AG14366] Funding Source: Medline
- NINDS NIH HHS [NS38375] Funding Source: Medline
Ask authors/readers for more resources
Fibrillar alpha -synuclein is a component of the Lewy body, the characteristic neuronal inclusion of the Parkinson's disease (PD) brain. Both alpha -synuciein mutations linked to autosomal dominant early-onset forms of PD promote the in vitro conversion of the natively unfolded protein into ordered prefibrillar oligomers, suggesting that these protofibrils, rather than the fibril itself, may induce cell death. We report here that protofibrils differ markedly from fibrils with respect to their interactions with synthetic membranes. Protofibrillar alpha -synuclein, in contrast to the monomeric and the fibrillar forms, binds synthetic vesicles very tightly via a beta -sheet-rich structure and transiently permeabilizes these vesicles. The destruction of vesicular membranes by protofibrillar alpha -synuclein was directly observed by atomic force microscopy. The possibility that the toxicity of alpha -synuclein fibrillization may derive from an oligomeric intermediate, rather than the fibril, has implications regarding the design of therapeutics for PD.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available